Abstract A novel C 17 N Lycopodium alkaloid (LA), lycoplanine B (1), containing an unusual formyl group, along with two new LAs, lycoplanines C (2) and D (3), were isolated from the whole plant of Lycopodium complanatum. Their structures were elucidated by extensive NMR techniques, including 1D-and 2D-NMR experiments, as well as comparing their spectral data with those of the known analogues. A possible biogenetic pathway for 1 was also proposed.
Introduction
Lycopodium complanatum belonging to the family Lycopodiaceae, is mainly distributed in temperate and subtropical areas. This plant has been used as a folk medicine for the treatment of arthritic pain, quadriplegia, contusion, and blood stasis [1, 2] . Previous phytochemical investigations of this plant led to the isolation of a number of Lycopodium alkaloids (LAs) [3] [4] [5] [6] , which have attracted great interest from biogenetic [7, 8] , synthetic [9] [10] [11] , and biological [12, 13] points of view.
In our continuing efforts to find biogenetically interesting and structurally unique LAs, we reported a LA, lycoplanine A, posessing an intriguing tricyclic (6/9/5) ring skeleton from L. complanatum [14] . Further chemical investigation of the extracts of this plant resulted in the isolation of three new LAs, lycoplanines B-D (1-3), along with three known compounds lycopodine (4) , lycopodine N-oxide (5), and des-N-methyl-a-obscurine (6) . In current study, we describe the isolation, structure elucidation, and anti-AChE activity of 1-3 ( Fig. 1) , as well as a plausible biogenetic path for lycoplanine B (1). (Fig. 2) . The 1 H-1 H COSY spectrum of 1 revealed the presence of two fragments: a (C-3/C-4) and b (C-9/C-10/C-11/C-12/C-7/C-6, C-7/C-8/ C-15/C-16 and C-15/C-14). The connection of C-4 and C-6 through the ketone group (C-5) as evidenced by the HMBC correlations from H-3, H-4, H-6, and H-7 to a ketone group (d C 212.1). The connection of C-4 and C-12 through quaternary carbon (C-13) as evidenced by the HMBC correlations of H-3 and H-4 with quaternary carbon (d C 62.2), and H-4 with C-12. What's more, C-3 and C-17 was connected by sp 2 quaternary carbon (C-2), which was also elucidated by the HMBC correlations from H-3 to C-1, C-2, and C-17. Meanwhile, HMBC cross-peaks of H-9 with C-1 and C-13 established the connections of C-1, C-9, and C-13 through a nitrogen atom. In addation, HMBC correlations from H-10 to C-11 and C-12, H-14 to C-4, C-12, C-13, C-15, and C-16 could be observed. Thus, the basic planar structure of 1 was determined.
The relative configuration of 1 was elucidated by the ROESY spectrum (Fig. 2) and biogenetic consideration of lycopodine-type alkaloid derivatives isolated from Lycopodiaceae family. The cross-peaks of H-12 with H-8a, H-15 with H-6a were observed in ROESY experiment indicating the b-orientation of H-12 and H-15. The correlation of H-4 with H-11b indicated the a-orientation of H-4. Thus, the structure of compound 1 was characterized as 2-formyl-1,2-dehydro-lycopodine.
Lycoplanine C (2), obtained as colorless oil, had a molecular formula of C 16 H 23 NO 3 by the HRESIMS ion peak at m/z 278.
[M?H]
? (calcd for C 16 H 24 NO 3 , 278.1751) with six degrees of unsaturation. The IR absorption at 3414 cm -1 suggested the presence of hydroxy group. In agreement with its molecular formula, all the sixteen carbon signals were observed in the 13 C NMR spectrum (Table 1) , and were further classified by DEPT experiments into one methyl (d C 22.5), six methylenes, six methines (one olefinic at d C 123.2), and three quaternary carbons (one olefinic at d C 143.5, and one carbonyl at d C 210.1). The 1 H NMR (Table 1) . Careful comparison of the NMR spectroscopic data of 2 with those of lycoposerramine K [15] suggested that they possessed the same carbon skeleton. The fragments of a C-1/C-2/C-3/C-4, b C-9/C-10/C-11, and c C-6/C-7/C-8/C-15(C-16)/C-14 ( Fig. 3) determined by the 1 H-1 H COSY correlations (Fig. 3) , in combination with a series of HMBC correlations (Fig. 3 ) of H-9 with C-1 and C-13, H-1 with C-9 and C-13, H-4 with C-5, C-12 and C-13, H-6 with C-4, C-5 and C-12, and H-7 with C-11 and C-12, further confirmed the above deduction. The only difference between 2 and lycoposerramine K was that 2 possessed an additional hydroxy group connected to C-10, as inferred from the HMBC correlations of H-9 and H-11 with C-10 (d C 64.3).
The relative configuration of 2 was assigned on the basis of ROESY experiment. The ROESY correlations (Fig. 3 ) of H-15 with H-6, H-11 with H-7, H-10 with H-14a, and H-4 with H-9b indicated that H-4 and H-7 were a-oriented, while H-6, H-10 and H-15 were b-oriented. Therefore, compound 2 was unambiguously established as 10a-hydroxy-lycoposerramine K. Lycoplanine D (3) has the molecular formula C 16 methylenes, two methines, and five quaternary carbons (one amide, two olefinic carbons, and two sp3 quaternary carbons). Further 2D NMR analysis indicated that 3 should be a lycodine-type alkaloid with many similarities to that of des-N-methyl-a-obscurine [16] , which was also isolated in present study. Differing from des-N-methyl-a-obscurine, the molecular formula of 3 contains one more oxygen atom. Meanwhile, the methine group (d C 44.5) at C-12 in des-N-methyl-a-obscurine was replaced by a sp3 quaternary carbon (d C 70.3) in 3. So, the H-12 in des-N-methyl-aobscurine was replaced by a hydroxyl group in 3. The HMBC correlations of H-7, H-8, H-11, and H-14 with C-12 (d C 70.3) and C-13 (d C 60.5), further confirmed the above deduction. The relative configurations of 12-OH and H-15 were deduced to be b-oriented, according to the crosspeaks of H-11b/H-6b and H-15/H-6a in the ROESY spectrum. Therefore, compound 3 was determined as 12-hydroxy-des-N-methyl-a-obscurine. Lycoplanine B (1), a novel C 17 N Lycopodium alkaloid, is the first example of Lycopodium alkaloids containing an unusual formyl group. A possible biogenetic pathway for 1 was also proposed as shown in Scheme 1. Compound 1 might be generated from lycopodine (4) [17], which was also isolated from the plant in current study. In brief, 4 underwent oxidation step to produce intermediate i. Intermediate i give ii through a aldol addition reaction. Intermediate ii could then underwent oxidation reaction to yield key intermediate iii. Then, intermediate iii accompanied by a isomerization behaviors of the double bond to get 1.
Compounds 1-3 were also tested for AChE inhibitory activities using the Ellman method [18] reported previously (huperzine A as positive control, IC 50 = 0.03 lM). Unfortunately, they showed no inhibitory activity (IC 50-[ 100 lM) after two repeated experiments.
Experimental

General
Optical rotations were measured with a Horiba SEPA-300 polarimeter (Horiba, Tokyo, Japan). UV spectra were obtained using a Shimadzu UV-2401A spectrophotometer (Shimadzu, Tokyo, Japan). IR spectra were obtained by a Tenor 27 spectrophotometer (Bruker Optics, Ettlingen, Germany) using KBr pellets. 1D and 2D NMR spectra were carried out on Bruker AM-400, DRX-500, or AVANCE III-600 spectrometers with TMS as an internal standard (Bruker, Karlsruhe, Germany). ESIMS and HRESIMS were run on an Agilent 6530 Q of spectrometer (Agilent, Palo Alto, CA, USA). Column chromatography (CC) was performed using MCI gel (CHP 20P, 75-150 m; Mitsubishi Chemical Corporation, Tokyo, Japan), Polyamide (PA, 80-100 mesh; Sinopharm Chemical Reagent Co., Ltd, Shanghai, China) and silica gel (100-200 or 200-300 mesh; Qingdao Haiyang Chemical Co., Ltd, Qingdao, China). Thin-layer chromatography (TLC) was conducted on silica gel plates GF 254 (Qingdao Haiyang Chemical Co., Ltd, Qingdao, China). Fractions were monitored by TLC using various solvent systems, and spots were visualized by spraying improved Dragendorff's reagent to the silica gel plates or by heating silica gel plates sprayed with 10% H 2 SO 4 in EtOH.
Plant Material
The whole plants of Lycopodium complanatum were collected in Guizhou Province, People's Republic of China, in September 2013. The sample was identified by Dr. Xiao Cheng. A voucher specimen (20130915) 
Extraction and Isolation
The air-dried and powdered sample (30 kg) was extracted with 60% EtOH (24 h 9 3), the extract was partitioned between EtOAc and 1.0% HCl/H 2 O. Water-soluble materials, which were adjusted to pH 10 with saturated Na 2 CO 3 aq, were extracted with CHCl 3 to give an alkaloidal extract (60 g). (3.5 g) was purified by silica gel CC (CHCl 3 /MeOH, 80:1-10:1) to obtain 1 (5 mg). Fraction C (18 g) was subjected to silica gel CC (petroleum ether/Me 2 CO, from 9:1 to 4:1) to give six subfractions, fractions C1-C6. Fraction C3 (5.4 g) was submitted to silica gel CC (CHCl 3 / MeOH, 50:1-10:1) to yield 2 (3 mg) and 4 (30 mg). Fraction D (11 g) was successively subjected to RP-18 (30% MeOH/H 2 O) to give three subfractions, fractions D1-D3. Fraction D3 (4.5 g) was further purified by a silica gel column chromatography (CHCl 3 /MeOH, 200:1) and Sephadex LH-20 to afford 3 (6 mg) and 5 (8 mg).
Lycoplanine B (1)
White amorphous powder; ½a 
Acetylcholinesterase Inhibition Activity
Acetylcholinesterase (AChE) inhibitory activity of compounds 1-3 were assayed by the spectrophotometric method developed by Ellman et al. with slightly modification (Ellman et al. 1961 ). S-Acetylthiocholine iodide, Sbutyrylthiocholine iodide,5,5 0 -dithio-bis-(2-nitrobenzoic) acid (DTNB, Ellman's reagent), acetylcholinesterase derived from human erythrocytes were purchased from Sigma Chemical. Compounds 1-3 were dissolved in DMSO. The reaction mixture (totally 200 lL) containing phosphate buffer (pH 8.0), test compound (50 lM), and acetyl cholinesterase (0.02 U/mL), was incubated for 20 min (30°C). Then, the reaction was initiated by the addition of 40 lL of solution containing DTNB (0.625 mM) and acetylthiocholine iodide (0.625 mM) for AChE inhibitory activity assay, respectively. The hydrolysis of acetylthiocholine was monitored at 405 nm every 30 s for 1 h. Tacrine was used as positive control with final concentration of 0.333 lM. All the reactions were performed in triplicate. The percentage inhibition was calculated as follows: % inhibition = (E -S)/E 9 100 (E is the activity of the enzyme without test compound and S is the activity of enzyme with test compound).
